Plunkett Research Online: XORTX Therapeutics

XORTX THERAPEUTICS (XRX:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

XORTX Therapeutics Inc is focused on developing drug therapies for the orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes......



XORTX Therapeutics
Ticker: XRX
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 1 403 607-2621
Fax: 1 403 260-3501
Address: 421 - 7th Avenue SW
Suite 4000
Calgary, AB T2P 4K9 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription

XORTX Therapeutics Inc is focused on developing drug therapies for the orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172017201620162015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: